Febrile neutropenia during acute myeloid leukemia therapy: Single institution experience from a developing country

被引:0
|
作者
Gupta, A. [1 ]
Singh, M. [1 ]
Singh, H. [1 ]
Kumar, L. [1 ]
Sharma, A. [1 ]
Bakhshi, S. [1 ]
Raina, V. [1 ]
Thulkar, S. [1 ]
机构
[1] IRCH, New Delhi, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18000
引用
收藏
页数:2
相关论文
共 50 条
  • [1] MAINTAINENCE THERAPY IN ACUTE MYELOID LEUKEMIA: EXPERIENCE FROM A DEVELOPING COUNTRY
    Jain, K.
    Udgire, S.
    Mudaliar, S.
    Swami, A.
    Shah, N.
    Desai, M.
    Agarwal, B.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S324 - S324
  • [2] Analysis of 210 febrile neutropenic episodes during induction therapy of acute myeloid leukemia (AML): An institutional experience from a developing country
    Konatam, M. L.
    Rajappa, S.
    Digumarti, R.
    Maddali, L. S.
    Vemu, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Febrile neutropenia in children with acute lymphoblastic leukemia: single center experience
    Ozdemir, Nihal
    Tuysuz, Gulen
    Celik, Nigar
    Yantri, Leman
    Erginoz, Ethem
    Apak, Hilmi
    Ozkan, Alp
    Yildiz, Inci
    Celkan, Tiraje
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2016, 51 (02): : 79 - 86
  • [4] Prognostic Factors in Childhood Acute Myeloid Leukemia; Experience from A Developing Country
    Ghafoor, Tariq
    Khalil, Sumaira
    Farah, Tanzeela
    Ahmed, Shakeel
    Sharif, Imtenan
    CANCER REPORTS, 2020, 3 (05)
  • [5] Hematological and immunophenotypic profile of acute myeloid leukemia: An experience from a developing country
    Kushwaha, R.
    Chauhan, S.
    Kumar, A.
    Singh, U. S.
    Jain, A. I.
    Verma, S. P.
    Kumar, M.
    Babu, S.
    VIRCHOWS ARCHIV, 2016, 469 : S290 - S290
  • [6] CYTOGENETIC FINDINGS IN ACUTE MYELOID LEUKEMIA: A DEVELOPING COUNTRY EXPERIENCE
    Mohammed, R.
    Yadav, S. P.
    Meena, L.
    Verma, I. C.
    Sachdeva, A.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 228 - 228
  • [7] Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia
    Hochart, C.
    Berthon, C.
    Corm, S.
    Gay, J.
    Cliquennois, M.
    Tricot, S.
    Alfandari, S.
    MEDECINE ET MALADIES INFECTIEUSES, 2011, 41 (12): : 652 - 656
  • [8] Venetoclax combination therapy in relapsed/refractory acute myeloid leukemia: A single institution experience
    Gaut, Daria
    Burkenroad, Aaron
    Duong, Tuyen
    Feammelli, Jesse
    Sasine, Joshua
    Schiller, Gary
    LEUKEMIA RESEARCH, 2020, 90
  • [9] MICROBIOLOGICAL PROFILE OF FEBRILE NEUTROPENIA IN PATIENTS WITH ACUTE MYELOID LEUKEMIA. CENTER EXPERIENCE
    Solis, L.
    Gonzalo, C.
    Sabater, M.
    Serrano, A.
    Bengochea, M. L.
    Mendez, G.
    Rodrigo, E.
    Varea, S.
    Mari, P.
    Llorente, L.
    Perez de Oteyza, J.
    HAEMATOLOGICA, 2017, 102 : 320 - 320
  • [10] Matched sibling vs haploidentical transplant for acute myeloid leukemia: A single centre experience from developing country
    Prabhu, Shilpa
    Damodar, Sharat
    Nataraj, K. S.
    Bhat, Sunil
    Annapandian, V. M.
    Badiger, Shobha
    Vasundhara, K.
    Chaudhary, Ruchi
    BONE MARROW TRANSPLANTATION, 2019, 54 : 156 - 157